| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Patou Gary is a Director at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 2 buys and 8 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | Director | Sale+OE | 4,891 | $41.08 | $200,946.61 | -9.4% | -4.3% | +0.0% | |
| Dec 13, 2023 | XENE Xenon Pharmaceuticals Inc. | Director | Sale+OE | 18,978 | $39.99 | $758,982.88 | -20.1% | +10.9% | -1.1% | |
| Nov 25, 2022 | XENE Xenon Pharmaceuticals Inc. | Director | Sale+OE | 3,994 | $34.55 | $137,999.97 | -7.8% | +10.1% | -16.8% | |
| Aug 10, 2017 | XENE Xenon Pharmaceuticals Inc. | Director | Buy | 7,500 | $2.78 | $20,835.75 | +150.0% | - | - | |
| Aug 8, 2017 | XENE Xenon Pharmaceuticals Inc. | Director | Buy | 5,000 | $3.00 | $15,002.50 | New | - | - |